查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1609551

體外診斷市場規模、佔有率、趨勢分析報告：按產品、按測試地點、按最終用途、按技術、按應用、按地區、細分市場預測，2025-2030

In Vitro Diagnostics Market Size, Share & Trends Analysis Report By Product, By Test Location, By End-use, By Technology, By Application, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 200 Pages | 商品交期: 2-10個工作天內

價格

體外診斷市場成長與趨勢

Grand View Research, Inc.最新報告顯示，預計到2030年，全球體外診斷市場規模將達1,187.2億美元。

老年人口的增加、COVID-19 大流行以及診斷技術的進步正在推動這種技術的採用，預計在預測期內複合年成長率為 6.75%。可移植性、準確性和成本效益的技術進步預計將成為最有影響力的渲染促進因素。 COVID-19 IVD 診斷的推出進一步加速了技術進步，加強了 PCR 等技術設備和耗材的採用。市場上的競爭對手擴大採用合約和夥伴關係策略來維持製造商和用戶的持續業務流。

這些合約也是政府實驗室嚴格價格控制策略的結果，壓低了政府環境中的價格。例如，2021 年 4 月，Seegene, Inc. 的義大利子公司對公共採購進行了 1.0825 億美元的競標，用於供應 715 萬份 SARS-CoV-2 診斷檢測試劑和萃取試劑。 SARS-CoV-2診斷檢測的主要目的是提供SARS-CoV-2診斷檢測和SARS-CoV-2萃取試劑，增加了多方交易和供應鏈的複雜性。全球癌症和心血管疾病 (CVD) 的高盛行率預計將推動診斷創新，以促進早期診斷並滿足消費者不斷變化的需求。等離子 PCR 等新技術預計將在預測期內進入商業性市場，從而對現有產品的業務產生負面影響。

體外診斷市場報告亮點

  • 由於採用率和使用率不斷上升，分子診斷預計將從 2025 年到 2030 年以複合年成長率成長最快。
  • 由於基因檢測需求的快速成長以及臨床需求未滿足的低收入和中等收入國家技術先進的診斷檢測的可用性不斷增加，試劑佔據了最大的市場佔有率。
  • 由於全球進行了大量的傳染病檢查，感染疾病應用領域佔據了最大的市場佔有率。
  • 由於對新技術的高需求、大量關鍵參與企業、高盛行率和先進的醫療基礎設施，北美將在 2024 年主導全球市場。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第3章體外診斷市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/輔助市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 體外診斷市場分析工具
    • 波特的分析
    • PESTEL分析
  • 消費行為分析
  • 價格分析
    • 裝置
    • 試劑

第4章體外診斷市場：依產品分類的估算與趨勢分析

  • 細分儀表板
  • 體外診斷市場：2024 年和 2030 年產品變化分析
  • 裝置
  • 試劑
  • 服務

第5章 體外診斷市場：技術估算與趨勢分析

  • 細分儀表板
  • 體外診斷市場：2024年及2030年技術波動分析
  • 免疫檢測
    • 裝置
    • 試劑
    • 服務
  • 血
    • 裝置
    • 試劑
    • 服務
  • 臨床化學
    • 裝置
    • 試劑
    • 服務
  • 分子診斷
    • 裝置
    • 試劑
    • 服務
  • 凝固
    • 裝置
    • 試劑
    • 服務
  • 微生物
    • 裝置
    • 試劑
    • 服務
  • 其他
    • 裝置
    • 試劑
    • 服務

第6章體外診斷市場：按應用、估計和趨勢分析

  • 細分儀表板
  • 體外診斷市場：2024 年和 2030 年應用變化分析
  • 感染疾病
  • 糖尿病
  • 腫瘤學/癌症
  • 心臟病學
  • 腎臟病學
  • 自體免疫疾病
  • 藥物測試
  • 其他

第7章 體外診斷市場：依檢測地點估算與趨勢分析

  • 細分儀表板
  • 體外診斷市場：2024 年和 2030 年測試地點變化分析
  • 照護現場
  • 居家醫療
  • 其他

第8章體外診斷市場：依最終用途分類的估計與趨勢分析

  • 細分儀表板
  • 體外診斷市場：最終用途變化分析，2024 年和 2030 年
  • 醫院
  • 實驗室
  • 居家醫療
  • 其他

第9章體外診斷市場：區域、估計和趨勢分析

  • 2024 年及 2030 年體外診斷市場佔有率（按地區）
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 瑞典
    • 丹麥
    • 挪威
    • 俄羅斯
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 泰國
    • 新加坡
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東/非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
    • 科威特

第10章競爭格局

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司分類
  • 2024年全球企業市場佔有率分析
  • 企業熱力圖分析
  • 策略規劃
    • 擴張
    • 併購
    • 夥伴關係與協作
    • 新產品發布
    • 研究與開發
  • 公司簡介
    • QIAGEN
    • BD
    • bioMerieux SA
    • F. Hoffmann-La Roche, Ltd.
    • QuidelOrtho Corporation
    • Abbott
    • Agilent Technologies, Inc.
    • Siemens Healthineers AG
    • Bio-Rad Laboratories, Inc.
    • Danaher
    • Sysmex Corporation
    • Charles River Laboratories
    • Quest Diagnostics Incorporated
Product Code: 978-1-68038-080-4

In Vitro Diagnostic Market Growth & Trends:

The global in vitro diagnostics market size is expected to reach USD 118.72 billion by 2030, according to a new report by Grand View Research, Inc. It is estimated to register a CAGR of 6.75% over the forecast period driven by the increasing geriatric population, COVID-19 pandemic, and technological advancements in diagnostics that are supporting its adoption. Technological advancements in terms of portability, accuracy, and cost-effectiveness are projected to be one of the high-impact rendering drivers. Technological advancements were further accelerated by the launch of COVID-19 IVD diagnostics and enhanced the adoption of instruments and consumables for technologies, such as PCR. Competitors in the market are increasingly adopting agreement and partnership strategies to maintain a constant flow of business for manufacturers & diagnostics for users.

These agreements are also a result of the harsh price containment strategies for government laboratories, which lowers the price in government settings. For instance, in April 2021, the Italian subsidiary of Seegene, Inc. received a USD 108.25 million tenders for public procurement for the supply of extraction reagents, as well as 7.15 million SARS-CoV-2 diagnostic tests. However, it increases the multiparty nature and complexity of the supply chain. The high prevalence of cancer and Cardiovascular Diseases (CVDs) globally is anticipated to drive diagnostic innovation to facilitate early diagnosis and meet the constantly evolving needs of consumers. Novel technologies, such as plasmonic PCR, are anticipated to commercially enter the market during the forecast period, influencing the business of existing products adversely.

In Vitro Diagnostics Market Report Highlights:

  • Molecular diagnostics is anticipated to grow at the fastest CAGR from 2025 to 2030 owing to the rising adoption and usage rate
  • Reagents held the largest market share owing to the surge in demand for genetic testing and enhanced availability of technologically advanced diagnostic tests in lower and middle-income countries with unmet clinical needs
  • The infectious diseases application segment held the largest market share owing to the large volume of testing for infectious diseases globally
  • North America dominated the global market in 2024 owing to the high demand for novel technologies, a large pool of key players, high prevalence of diseases, and advanced healthcare infrastructure

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
    • 1.2.1. Product
    • 1.2.2. Technology
    • 1.2.3. Application
    • 1.2.4. Test Location
    • 1.2.5. End Use
  • 1.3. Regional Scope
  • 1.4. Estimates and Forecast Timeline
  • 1.5. Research Methodology
  • 1.6. Information Procurement
    • 1.6.1. Purchased Database
    • 1.6.2. GVR's Internal Database
  • 1.7. Details of primary research
  • 1.8. Market Formulation & Validation
  • 1.9. Model Details
    • 1.9.1. Commodity flow analysis (Model 1)
      • 1.9.1.1. Approach 1: Commodity flow approach
    • 1.9.2. Volume price analysis (Model 2)
      • 1.9.2.1. Approach 2: Volume price analysis
  • 1.10. Research Scope and Assumptions
    • 1.10.1. List of Secondary Sources
    • 1.10.2. List of Primary Sources
    • 1.10.3. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. In Vitro Diagnostics Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Drivers Analysis
      • 3.2.1.1. Growing Geriatric Population
      • 3.2.1.2. Technological Advancements
      • 3.2.1.3. Increasing Demand For PoC Facilities
      • 3.2.1.4. Growing prevalence of target diseases
      • 3.2.1.5. Outbreak Of Covid-19
    • 3.2.2. Market Restraints Analysis
      • 3.2.2.1. Higher Cost Of Devices
      • 3.2.2.2. Stringent Regulatory Policies
  • 3.3. In Vitro Diagnostics Market Analysis Tools
    • 3.3.1. Porter's Analysis
      • 3.3.1.1. Bargaining power of the suppliers
      • 3.3.1.2. Bargaining power of the buyers
      • 3.3.1.3. Threats of substitution
      • 3.3.1.4. Threats from new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic and Social landscape
      • 3.3.2.3. Technological landscape
      • 3.3.2.4. Legal landscape
  • 3.4. Consumer Behavior Analysis
  • 3.5. Pricing Analysis
    • 3.5.1. Instruments
    • 3.5.2. Reagents

Chapter 4. In Vitro Diagnostics Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. In Vitro Diagnostics Market: Product Movement Analysis, 2024 & 2030 (USD Million) (Volume Analysis)
  • 4.3. Instruments
    • 4.3.1. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold)
  • 4.4. Reagents
    • 4.4.1. Reagents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Tests Sold)
  • 4.5. Services
    • 4.5.1. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. In Vitro Diagnostics Market: Technology Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. In Vitro Diagnostics Market: Technology Movement Analysis, 2024 & 2030 (USD Million) (Volume Analysis)
  • 5.3. Immunoassay
    • 5.3.1. Immunoassay Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.2. Instruments
      • 5.3.2.1. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.3. Reagents
      • 5.3.3.1. Reagents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.4. Services
      • 5.3.4.1. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Hematology
    • 5.4.1. Hematology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.2. Instruments
      • 5.4.2.1. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.3. Reagents
      • 5.4.3.1. Reagents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.4. Services
      • 5.4.4.1. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Clinical Chemistry
    • 5.5.1. Clinical Chemistry Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.5.2. Instruments
      • 5.5.2.1. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.5.3. Reagents
      • 5.5.3.1. Reagents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.5.4. Services
      • 5.5.4.1. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Molecular Diagnostics
    • 5.6.1. Molecular Diagnostics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.6.2. Instruments
      • 5.6.2.1. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.6.3. Reagents
      • 5.6.3.1. Reagents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.6.4. Services
      • 5.6.4.1. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7. Coagulation
    • 5.7.1. Coagulation Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.7.2. Instruments
      • 5.7.2.1. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.7.3. Reagents
      • 5.7.3.1. Reagents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.7.4. Services
      • 5.7.4.1. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.8. Microbiology
    • 5.8.1. Microbiology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.8.2. Instruments
      • 5.8.2.1. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.8.3. Reagents
      • 5.8.3.1. Reagents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.8.4. Services
      • 5.8.4.1. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.9. Others
    • 5.9.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.9.2. Instruments
      • 5.9.2.1. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.9.3. Reagents
      • 5.9.3.1. Reagents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.9.4. Services
      • 5.9.4.1. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. In Vitro Diagnostics Market: Application Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. In Vitro Diagnostics Market: Application Movement Analysis, 2024 & 2030 (USD Million)
  • 6.3. Infectious Disease
    • 6.3.1. Infectious Disease Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Diabetes
    • 6.4.1. Diabetes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Oncology/Cancer
    • 6.5.1. Oncology/Cancer Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Cardiology
    • 6.6.1. Cardiology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7. Nephrology
    • 6.7.1. Nephrology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.8. Autoimmune Diseases
    • 6.8.1. Autoimmune Diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.9. Drug Testing
    • 6.9.1. Drug Testing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.10. Others
    • 6.10.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. In Vitro Diagnostics Market: Test Location Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. In Vitro Diagnostics Market: Test Location Movement Analysis, 2024 & 2030 (USD Million)
  • 7.3. Point of Care
    • 7.3.1. Point of Care Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4. Home-care
    • 7.4.1. Home-care Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Others
    • 7.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. In Vitro Diagnostics Market: End Use Estimates & Trend Analysis

  • 8.1. Segment Dashboard
  • 8.2. In Vitro Diagnostics Market: End Use Movement Analysis, 2024 & 2030 (USD Million)
  • 8.3. Hospitals
    • 8.3.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4. Laboratory
    • 8.4.1. Laboratory Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5. Home Care
    • 8.5.1. Home Care Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6. Others
    • 8.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. In Vitro Diagnostics Market: Regional Estimates & Trend Analysis

  • 9.1. In Vitro Diagnostics Market Share, By Region, 2024 & 2030 (USD Million)
  • 9.2. North America
    • 9.2.1. North America In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
    • 9.2.2. U.S.
      • 9.2.2.1. Key Country Dynamics
      • 9.2.2.2. Regulatory Landscape/Reimbursement Scenario
      • 9.2.2.3. Competitive Insights
      • 9.2.2.4. U.S. In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
    • 9.2.3. Canada
      • 9.2.3.1. Key Country Dynamics
      • 9.2.3.2. Regulatory Landscape/Reimbursement Scenario
      • 9.2.3.3. Competitive Insights
      • 9.2.3.4. Canada In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
    • 9.2.4. Mexico
      • 9.2.4.1. Key Country Dynamics
      • 9.2.4.2. Regulatory Landscape/Reimbursement Scenario
      • 9.2.4.3. Competitive Insights
      • 9.2.4.4. Mexico In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
  • 9.3. Europe
    • 9.3.1. Europe In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
    • 9.3.2. UK
      • 9.3.2.1. Key Country Dynamics
      • 9.3.2.2. Regulatory Landscape/Reimbursement Scenario
      • 9.3.2.3. Competitive Insights
      • 9.3.2.4. UK In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.3.3. Germany
      • 9.3.3.1. Key Country Dynamics
      • 9.3.3.2. Regulatory Landscape/Reimbursement Scenario
      • 9.3.3.3. Competitive Insights
      • 9.3.3.4. Germany In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
    • 9.3.4. France
      • 9.3.4.1. Key Country Dynamics
      • 9.3.4.2. Regulatory Landscape/Reimbursement Scenario
      • 9.3.4.3. Competitive Insights
      • 9.3.4.4. France In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
    • 9.3.5. Italy
      • 9.3.5.1. Key Country Dynamics
      • 9.3.5.2. Regulatory Landscape/Reimbursement Scenario
      • 9.3.5.3. Competitive Insights
      • 9.3.5.4. Italy In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
    • 9.3.6. Spain
      • 9.3.6.1. Key Country Dynamics
      • 9.3.6.2. Regulatory Landscape/Reimbursement Scenario
      • 9.3.6.3. Competitive Insights
      • 9.3.6.4. Spain In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
    • 9.3.7. Sweden
      • 9.3.7.1. Key Country Dynamics
      • 9.3.7.2. Regulatory Landscape/Reimbursement Scenario
      • 9.3.7.3. Competitive Insights
      • 9.3.7.4. Sweden In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
    • 9.3.8. Denmark
      • 9.3.8.1. Key Country Dynamics
      • 9.3.8.2. Regulatory Landscape/Reimbursement Scenario
      • 9.3.8.3. Competitive Insights
      • 9.3.8.4. Denmark In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
    • 9.3.9. Norway
      • 9.3.9.1. Key Country Dynamics
      • 9.3.9.2. Regulatory Landscape/Reimbursement Scenario
      • 9.3.9.3. Competitive Insights
      • 9.3.9.4. Norway In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
    • 9.3.10. Russia
      • 9.3.10.1. Key Country Dynamics
      • 9.3.10.2. Regulatory Landscape/Reimbursement Scenario
      • 9.3.10.3. Competitive Insights
      • 9.3.10.4. Russis In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
  • 9.4. Asia Pacific
    • 9.4.1. Asia Pacific In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
    • 9.4.2. China
      • 9.4.2.1. Key Country Dynamics
      • 9.4.2.2. Regulatory Landscape/Reimbursement Scenario
      • 9.4.2.3. Competitive Insights
      • 9.4.2.4. China In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
    • 9.4.3. Japan
      • 9.4.3.1. Key Country Dynamics
      • 9.4.3.2. Regulatory Landscape/Reimbursement Scenario
      • 9.4.3.3. Competitive Insights
      • 9.4.3.4. Japan In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
    • 9.4.4. India
      • 9.4.4.1. Key Country Dynamics
      • 9.4.4.2. Regulatory Landscape/Reimbursement Scenario
      • 9.4.4.3. Competitive Insights
      • 9.4.4.4. India In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
    • 9.4.5. South Korea
      • 9.4.5.1. Key Country Dynamics
      • 9.4.5.2. Regulatory Landscape/Reimbursement Scenario
      • 9.4.5.3. Competitive Insights
      • 9.4.5.4. South Korea In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
    • 9.4.6. Australia
      • 9.4.6.1. Key Country Dynamics
      • 9.4.6.2. Regulatory Landscape/Reimbursement Scenario
      • 9.4.6.3. Competitive Insights
      • 9.4.6.4. Australia In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
    • 9.4.7. Thailand
      • 9.4.7.1. Key Country Dynamics
      • 9.4.7.2. Regulatory Landscape/Reimbursement Scenario
      • 9.4.7.3. Competitive Insights
      • 9.4.7.4. Thailand In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
    • 9.4.8. Singapore
      • 9.4.8.1. Key Country Dynamics
      • 9.4.8.2. Regulatory Landscape/Reimbursement Scenario
      • 9.4.8.3. Competitive Insights
      • 9.4.8.4. Singapore In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
  • 9.5. Latin America
    • 9.5.1. Latin America In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
    • 9.5.2. Brazil
      • 9.5.2.1. Key Country Dynamics
      • 9.5.2.2. Regulatory Landscape/Reimbursement Scenario
      • 9.5.2.3. Competitive Insights
      • 9.5.2.4. Brazil In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
    • 9.5.3. Argentina
      • 9.5.3.1. Key Country Dynamics
      • 9.5.3.2. Regulatory Landscape/Reimbursement Scenario
      • 9.5.3.3. Competitive Insights
      • 9.5.3.4. Argentina In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
  • 9.6. Middle East and Africa
    • 9.6.1. Middle East and Africa In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.6.2. Saudi Arabia
      • 9.6.2.1. Key Country Dynamics
      • 9.6.2.2. Regulatory Landscape/Reimbursement Scenario
      • 9.6.2.3. Competitive Insights
      • 9.6.2.4. Saudi Arabia In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
    • 9.6.3. UAE
      • 9.6.3.1. Key Country Dynamics
      • 9.6.3.2. Regulatory Landscape/Reimbursement Scenario
      • 9.6.3.3. Competitive Insights
      • 9.6.3.4. UAE In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
    • 9.6.4. South Africa
      • 9.6.4.1. Key Country Dynamics
      • 9.6.4.2. Regulatory Landscape/Reimbursement Scenario
      • 9.6.4.3. Competitive Insights
      • 9.6.4.4. South Africa In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
    • 9.6.5. Kuwait
      • 9.6.5.1. Key Country Dynamics
      • 9.6.5.2. Regulatory Landscape/Reimbursement Scenario
      • 9.6.5.3. Competitive Insights
      • 9.6.5.4. Kuwait In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)

Chapter 10. Competitive Landscape

  • 10.1. Recent Developments & Impact Analysis by Key Market Participants
  • 10.2. Company Categorization
  • 10.3. Global Company Market Share Analysis, 2024
  • 10.4. Company Heat Map Analysis
  • 10.5. Strategy Mapping
    • 10.5.1. Expansion
    • 10.5.2. Mergers & Acquisition
    • 10.5.3. Partnerships & Collaborations
    • 10.5.4. New Product Launches
    • 10.5.5. Research And Development
  • 10.6. Company Profiles
    • 10.6.1. QIAGEN
      • 10.6.1.1. Participant's Overview
      • 10.6.1.2. Financial Performance
      • 10.6.1.3. Product Benchmarking
      • 10.6.1.4. Recent Developments
    • 10.6.2. BD
      • 10.6.2.1. Participant's Overview
      • 10.6.2.2. Financial Performance
      • 10.6.2.3. Product Benchmarking
      • 10.6.2.4. Recent Developments
    • 10.6.3. bioMerieux SA
      • 10.6.3.1. Participant's Overview
      • 10.6.3.2. Financial Performance
      • 10.6.3.3. Product Benchmarking
      • 10.6.3.4. Recent Developments
    • 10.6.4. F. Hoffmann-La Roche, Ltd.
      • 10.6.4.1. Participant's Overview
      • 10.6.4.2. Financial Performance
      • 10.6.4.3. Product Benchmarking
      • 10.6.4.4. Recent Developments
    • 10.6.5. QuidelOrtho Corporation
      • 10.6.5.1. Participant's Overview
      • 10.6.5.2. Financial Performance
      • 10.6.5.3. Product Benchmarking
      • 10.6.5.4. Recent Developments
    • 10.6.6. Abbott
      • 10.6.6.1. Participant's Overview
      • 10.6.6.2. Financial Performance
      • 10.6.6.3. Product Benchmarking
      • 10.6.6.4. Recent Developments
    • 10.6.7. Agilent Technologies, Inc.
      • 10.6.7.1. Participant's Overview
      • 10.6.7.2. Financial Performance
      • 10.6.7.3. Product Benchmarking
      • 10.6.7.4. Recent Developments
    • 10.6.8. Siemens Healthineers AG
      • 10.6.8.1. Participant's Overview
      • 10.6.8.2. Financial Performance
      • 10.6.8.3. Product Benchmarking
      • 10.6.8.4. Recent Developments
    • 10.6.9. Bio-Rad Laboratories, Inc.
      • 10.6.9.1. Participant's Overview
      • 10.6.9.2. Financial Performance
      • 10.6.9.3. Product Benchmarking
      • 10.6.9.4. Recent Developments
    • 10.6.10. Danaher
      • 10.6.10.1. Participant's Overview
      • 10.6.10.2. Financial Performance
      • 10.6.10.3. Product Benchmarking
      • 10.6.10.4. Recent Developments
    • 10.6.11. Sysmex Corporation
      • 10.6.11.1. Participant's Overview
      • 10.6.11.2. Financial Performance
      • 10.6.11.3. Product Benchmarking
      • 10.6.11.4. Recent Developments
    • 10.6.12. Charles River Laboratories
      • 10.6.12.1. Participant's Overview
      • 10.6.12.2. Financial Performance
      • 10.6.12.3. Product Benchmarking
      • 10.6.12.4. Recent Developments
    • 10.6.13. Quest Diagnostics Incorporated
      • 10.6.13.1. Participant's Overview
      • 10.6.13.2. Financial Performance
      • 10.6.13.3. Product Benchmarking
      • 10.6.13.4. Recent Developments

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Regulatory Framework
  • Table 4 Global In Vitro Diagnostics Market, By Region, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in million)
  • Table 5 Global In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in million)
  • Table 6 Global In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in million)
  • Table 7 Global In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in million)
  • Table 8 Global In Vitro Diagnostics Market, By End-use, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in million)
  • Table 9 Global In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in million)
  • Table 10 North America In Vitro Diagnostics Market, By Country, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 11 North America In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 12 North America In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 13 North America In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 14 North America In Vitro Diagnostics Market, By End-use, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 15 North America In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in million)
  • Table 16 U.S. In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 17 U.S. In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 18 U.S. In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 19 U.S. In Vitro Diagnostics Market, By End-use, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 20 U.S. In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in million)
  • Table 21 Canada In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 22 Canada In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 23 Canada In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 24 Canada In Vitro Diagnostics Market, By End-use, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 25 Canada In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in million)
  • Table 26 Mexico In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 27 Mexico In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 28 Mexico In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 29 Mexico In Vitro Diagnostics Market, By End-use, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 30 Mexico In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in million)
  • Table 31 Europe In Vitro Diagnostics Market, By Country, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 32 Europe In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 33 Europe In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 34 Europe In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 35 Europe In Vitro Diagnostics Market, By End-use, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 36 Europe In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in million)
  • Table 37 UK In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 38 UK In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 39 UK In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 40 UK In Vitro Diagnostics Market, By End-use, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 41 UK In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in million)
  • Table 42 Germany In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 43 Germany In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 44 Germany In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 45 Germany America In Vitro Diagnostics Market, By End-use, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 46 Germany In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in million)
  • Table 47 France In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 48 France In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 49 France In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 50 France In Vitro Diagnostics Market, By End-use, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 51 France In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in million)
  • Table 52 Spain In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 53 Spain In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 54 Spain In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 55 Spain In Vitro Diagnostics Market, By End-use, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 56 Spain In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in million)
  • Table 57 Italy In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 58 Italy In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 58 Italy In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 60 Italy In Vitro Diagnostics Market, By End-use, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 61 Italy In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in million)
  • Table 62 Russia In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 63 Russia In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 64 Russia In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 65 Russia In Vitro Diagnostics Market, By End-use, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 66 Russia In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in million)
  • Table 67 Asia Pacific In Vitro Diagnostics Market, By Country, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 68 Asia Pacific In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 69 Asia Pacific In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 70 Asia Pacific In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 71 Asia-Pacific In Vitro Diagnostics Market, By End-use, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 72 Asia-Pacific In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in million)
  • Table 73 China In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 74 China In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 75 China In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 76 China In Vitro Diagnostics Market, By End-use, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 77 China In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in million)
  • Table 78 Japan In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 79 Japan In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 80 Japan In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 81 Japan In Vitro Diagnostics Market, By End-use, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 82 Japan In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in million)
  • Table 83 India In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 84 India In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 85 India In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 86 India In Vitro Diagnostics Market, By End-use, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 86 India In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in million)
  • Table 88 South Korea In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 89 South Korea In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 90 South Korea In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 91 South Korea In Vitro Diagnostics Market, By End-use, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 92 South Korea In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in million)
  • Table 93 Singapore In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 94 Singapore In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 95 Singapore In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 96 Singapore In Vitro Diagnostics Market, By End-use, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 97 Singapore In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in million)
  • Table 98 Australia In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 99 Australia In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 100 Australia In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 101 Australia In Vitro Diagnostics Market, By End-use, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 102 Australia In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in million)
  • Table 103 Latin America In Vitro Diagnostics Market, By Country, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 104 Latin America In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 105 Latin America In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 106 Latin America In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 107 Latin America In Vitro Diagnostics Market, By End-use, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 108 Latin America In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in million)
  • Table 109 Brazil In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 110 Brazil In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 111 Brazil In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 112 Brazil In Vitro Diagnostics Market, By End-use, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 113 Brazil In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in million)
  • Table 114 Argentina In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 115 Argentina In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 116 Argentina In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 117 Argentina In Vitro Diagnostics Market, By End-use, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 118 Argentina In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in million)
  • Table 119 MEA In Vitro Diagnostics Market, By Country, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 120 MEA In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 121 MEA In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 122 MEA In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 123 MEA In Vitro Diagnostics Market, By End-use, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 124 MEA In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in million)
  • Table 125 South Africa In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 126 South Africa In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 127 South Africa In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 128 South Africa In Vitro Diagnostics Market, By End-use, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 129 UAE In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in million)
  • Table 130 UAE In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 131 UAE In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 132 UAE In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 133 UAE In Vitro Diagnostics Market, By End-use, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 134 UAE In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in million)
  • Table 135 Saudi Arabia In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 136 Saudi Arabia In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 137 Saudi Arabia In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 138 Saudi Arabia In Vitro Diagnostics Market, By End-use, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 139 Saudi Arabia In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in million)

List of Figures

  • Fig. 1 In Vitro Diagnostics market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 In vitro diagnostic market snapshot
  • Fig. 10 Parent market outlook, 2024
  • Fig. 11 Penetration and growth prospect mapping
  • Fig. 12 In vitro diagnostic market driver impact
  • Fig. 13 Global elderly population
  • Fig. 14 New cancer cases by year
  • Fig. 15 In vitro diagnostic market restraint impact
  • Fig. 16 Market entry strategy
  • Fig. 17 SWOT analysis, by factor (political & legal, economic, and technological)
  • Fig. 18 Porter's five forces analysis
  • Fig. 19 Consumer behavior analysis
  • Fig. 20 Strategy mapping
  • Fig. 21 IVD market: Product outlook and key takeaways
  • Fig. 22 IVD market: Products movement analysis
  • Fig. 23 Instruments market estimates and forecast, 2018 - 2030 (USD Million) (Number of instruments installed in thousands)
  • Fig. 24 Reagents market estimates and forecast, 2018 - 2030 (USD Million), Number of reagents sold in millions
  • Fig. 25 Services market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 IVD market: Technology outlook and key takeaways
  • Fig. 27 IVD Market: Technology movement analysis
  • Fig. 28 Immunoassay market estimates and forecast, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Fig. 29 Instruments market for immunoassay estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 30 Reagents market for immunoassay estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 31 Services market for immunoassay estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 32 Hematology market estimates and forecast, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Fig. 33 Instruments market for hematology estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 34 Reagents market for hematology estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 35 Services market for hematology estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 36 Clinical chemistry market estimates and forecast, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Fig. 37 Instruments market for clinical chemistry estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 38 Reagents market for clinical chemistry estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 39 Services market for clinical chemistry estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 40 Molecular diagnostics market estimates and forecast, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Fig. 41 Instruments market for molecular diagnostics estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 42 Reagents market for molecular diagnostics estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 43 Services market for molecular diagnostics estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 44 Coagulation market estimates and forecast, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Fig. 45 Instruments market for coagulation estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 46 Reagents market for coagulation estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 47 Services market for coagulation estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 48 Microbiology market estimates and forecast, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Fig. 49 Instruments market for microbiology estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 50 Reagents market for microbiology estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 51 Services market for microbiology estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 52 Others market estimates and forecast, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Fig. 53 Instruments others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 54 Reagents others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 55 Services market for other technology estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 56 IVD market: Application outlook and key takeaways
  • Fig. 57 IVD market: Application movement analysis
  • Fig. 58 Infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 59 Diabetes market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 60 Oncology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 61 Cardiology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 62 Nephrology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 63 Autoimmune diseases market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 64 Drug testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 65 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 66 IVD market: End-use outlook and key takeaways
  • Fig. 67 IVD treatment market: End-use movement analysis
  • Fig. 68 Hospitals market estimates and forecast, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Fig. 69 Laboratory market estimates and forecast, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Fig. 70 Home care market estimates and forecast, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Fig. 71 Other market estimates and forecast, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Fig. 72 IVD market: test location outlook and key takeaways
  • Fig. 73 IVD treatment market: Test location movement analysis
  • Fig. 74 Point-of-care market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 75 Homecare market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 76 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 77 IVD Market: Regional outlook and key takeaways
  • Fig. 78 IVD market: Regional movement analysis
  • Fig. 79 North America
  • Fig. 80 North America, SWOT
  • Fig. 81 North America. market estimates and forecast, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Fig. 82 U.S. key country dynamics
  • Fig. 83 U.S. market estimates and forecast, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Fig. 84 Canada key country dynamics
  • Fig. 85 Canada market estimates and forecast, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Fig. 86 Mexico key country dynamics
  • Fig. 87 Mexico market estimates and forecast, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Fig. 88 Europe
  • Fig. 89 Europe, SWOT
  • Fig. 90 Europe market estimates and forecast, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Fig. 91 U.K. key country dynamics
  • Fig. 92 U.K. market estimates and forecast, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Fig. 93 Germany key country dynamics
  • Fig. 94 Germany market estimates and forecast, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Fig. 95 Spain key country dynamics
  • Fig. 96 Spain market estimates and forecast, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Fig. 97 France key country dynamics
  • Fig. 98 France market estimates and forecast, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Fig. 99 Italy key country dynamics
  • Fig. 100 Italy market estimates and forecast, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Fig. 101 Russia key country dynamics
  • Fig. 102 Russia market estimates and forecast, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Fig. 103 Denmark key country dynamics
  • Fig. 104 Denmark market estimates and forecast, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Fig. 105 Sweden key country dynamics
  • Fig. 106 Sweden market estimates and forecast, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Fig. 107 Norway key country dynamics
  • Fig. 108 Norway market estimates and forecast, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Fig. 109 Asia Pacific
  • Fig. 110 Asia Pacific, SWOT
  • Fig. 111 Asia Pacific market estimates and forecast, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Fig. 112 Japan key country dynamics
  • Fig. 113 Japan market estimates and forecast, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Fig. 114 China key country dynamics
  • Fig. 115 China. market estimates and forecast, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Fig. 116 India key country dynamics
  • Fig. 117 India. market estimates and forecast, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Fig. 118 South Korea key country dynamics
  • Fig. 119 South Korea market estimates and forecast, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Fig. 120 Singapore key country dynamics
  • Fig. 121 Singapore market estimates and forecast, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Fig. 122 Thailand key country dynamics
  • Fig. 123 Thailand market estimates and forecast, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Fig. 124 Australia key country dynamics
  • Fig. 125 Australia market estimates and forecast, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Fig. 126 Latin America
  • Fig. 127 Latin America, SWOT
  • Fig. 128 Latin America market estimates and forecast, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Fig. 129 Brazil key country dynamics
  • Fig. 130 Brazil market estimates and forecast, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Fig. 131 Argentina key country dynamics
  • Fig. 132 Argentina market estimates and forecast, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Fig. 133 Middle East & Africa
  • Fig. 134 Middle East & Africa, SWOT
  • Fig. 135 MEA market estimates and forecast, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Fig. 136 South Africa key country dynamics
  • Fig. 137 South Africa market estimates and forecast, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Fig. 138 United Arab Emirates key country dynamics
  • Fig. 139 United Arab Emirates market estimates and forecast, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Fig. 140 Saudi Arabia key country dynamics
  • Fig. 141 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Fig. 142 Ansoff matrix
  • Fig. 143 Competition categorization
  • Fig. 144 Company market share analysis, 2024
  • Fig. 145 Global mass spectrometry company market share analysis, 2024
  • Fig. 146 North America mass spectrometry company market share analysis, 2024
  • Fig. 147 Europe mass spectrometry company market share analysis, 2024
  • Fig. 148 Asia Pacific mass spectrometry company market share analysis, 2024
  • Fig. 149 Global immunoassay company market share analysis, 2024
  • Fig. 150 North America immunoassay company market share analysis, 2024
  • Fig. 151 Europe immunoassay company market share analysis, 2024
  • Fig. 152 Asia Pacific immunoassay company market share analysis, 2024
  • Fig. 153 Global PCR company market share analysis, 2024
  • Fig. 154 North America PCR company market share analysis, 2024
  • Fig. 155 Europe PCR company market share analysis, 2024
  • Fig. 156 Asia Pacific PCR company market share analysis, 2024
  • Fig. 157 Company market position analysis
  • Fig. 158 Company market position analysis
  • Fig. 159 Company market position analysis
  • Fig. 160 Company profiles
  • Fig. 161 Regional network map